Umb Bank, N.A. Novartis Ag Transaction History

Umb Bank, N.A.

$6.3 Billion
Q3 2024

A detailed history of Umb Bank, N.A. transactions in Novartis Ag stock. As of the latest transaction made, Umb Bank, N.A. holds 10,242 shares of NVS stock, worth $1.07 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

10,242

Previous 10,292 0.49%

Holding current value

$1.07 Million

Previous $1.1 Million 7.58%

% of portfolio

0.02%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$106.13 - $120.89 $5,306 - $6,044	-50 Reduced 0.49%	10,242 $1.18 Million
Q2 2024 Jul 29, 2024	SELL	$92.57 - $107.37 $9,534 - $11,059	-103 Reduced 0.99%	10,292 $1.1 Million
Q1 2024 Apr 26, 2024	SELL	$95.27 - $108.47 $47,253 - $53,801	-496 Reduced 4.55%	10,395 $1.01 Million
Q4 2023 Jan 23, 2024	SELL	$92.27 - $101.54 $71,509 - $78,693	-775 Reduced 6.64%	10,891 $1.1 Million
Q3 2023 Oct 18, 2023	SELL	$94.73 - $105.13 $53,048 - $58,872	-560 Reduced 4.58%	11,666 $1.19 Million
Q2 2023 Jul 25, 2023	SELL	$92.52 - $104.91 $9,992 - $11,330	-108 Reduced 0.88%	12,226 $1.23 Million
Q1 2023 Apr 11, 2023	BUY	$80.03 - $92.81 $70,666 - $81,951	883 Added 7.71%	12,334 $1.13 Million
Q4 2022 Jan 10, 2023	SELL	$75.55 - $92.52 $89,677 - $109,821	-1,187 Reduced 9.39%	11,451 $1.04 Million
Q3 2022 Oct 13, 2022	SELL	$74.61 - $87.26 $13,579 - $15,881	-182 Reduced 1.42%	12,638 $961,000
Q2 2022 Jul 20, 2022	SELL	$80.52 - $93.75 $76,171 - $88,687	-946 Reduced 6.87%	12,820 $1.08 Million
Q1 2022 Apr 22, 2022	SELL	$80.11 - $90.62 $3,284 - $3,715	-41 Reduced 0.3%	13,766 $1.21 Million
Q4 2021 Feb 09, 2022	BUY	$79.7 - $88.13 $1.1 Million - $1.22 Million	13,807 New	13,807 $1.21 Million

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.

Account